Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality -: A multicenter study

被引:540
作者
Mira, JP
Cariou, A
Grall, F
Delclaux, C
Losser, MR
Heshmati, F
Cheval, C
Monchi, M
Teboul, JL
Riché, F
Leleu, G
Arbibe, L
Mignon, A
Delpech, M
Dhainaut, JF
机构
[1] Cochin Port Royal Univ Hosp, Intens Care Unit, F-75679 Paris, France
[2] Cochin Port Royal Univ Hosp, Lab Biochem Genet, F-75679 Paris 14, France
[3] Lariboisiere Univ Hosp, Intens Care Unit, Paris, France
[4] St Joseph Univ Hosp, Paris, France
[5] Kremlin Bicetre Univ Hosp, Paris, France
[6] St Louis Univ Hosp, Paris, France
[7] Cochin Hosp, Blood Bank, Paris, France
[8] Mondor Univ Hosp, Creteil, France
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 282卷 / 06期
关键词
D O I
10.1001/jama.282.6.561
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Tumor necrosis factor alpha (TNF-alpha) is believed to be a cytokine central to pathogenesis of septic shock. TNF2, a polymorphism within the TNF-alpha gene pro meter, has been associated with enhanced TNF-alpha production and negative outcome in some severe infections. Objectives To investigate the frequency of the TNF2 allele in patients with septic shock and to determine whether the allele is associated with the occurrence and outcome of septic shock. Design Multicenter case-control study conducted from March 1996 to June 1997, Setting Seven medical intensive care units in university hospitals. Subjects Eighty-nine patients with septic shock and 87 healthy unrelated blood donors. Main Outcome Measures Frequency of the TNF2 allele among patients with septic shock and among those who died and the level of corresponding TNF-alpha concentrations. Results Mortality among patients with septic shock was 54%, consistent with the predicted mortality from the Simplified Acute Physiologic Score (SAPS II) value. The polymorphism frequencies of the controls and the patients with septic shock differed only at the TNF2 allele (39% vs 18% in the septic shock and control groups, respectively, P =.002). Among the septic shock patients, TNF2 polymorphism frequency was significantly greater among those who had died (52% vs 24% in the survival group. P =.008). Concentrations of TNF-alpha were higher in 68% and 52% with the TNF2 and TNF1 polymorphisms, respectively, but their median Values (48 pg/mL vs 29 pg/mL) were not statistically different (P =.31). After controlling for age and the probability of death, derived by the SAPS II score, multiple logistic regression analysis showed that, for the same rank of SAPS ii value, patients with the TNF2 allele had a 3.7-fold risk of death (95% confidence interval, 1.37-20.24). Conclusion The TNF2 allele is strongly associated with susceptibility to septic shock and death due to septic shock.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 50 条
  • [11] INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
    Cohen, J
    Carlet, J
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (09) : 1431 - 1440
  • [12] COLOMBANI J, 1993, EUROTEXT, P100
  • [13] Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid
    Conway, DJ
    Holland, MJ
    Bailey, RL
    Campbell, AE
    Mahdi, OSM
    Jennings, R
    Mbena, E
    Mabey, DCW
    [J]. INFECTION AND IMMUNITY, 1997, 65 (03) : 1003 - 1006
  • [14] PSORALEN-MODIFIED OLIGONUCLEOTIDE PRIMERS IMPROVE DETECTION OF MUTATIONS BY DENATURING GRADIENT GEL-ELECTROPHORESIS AND PROVIDE AN ALTERNATIVE TO GC-CLAMPING
    COSTES, B
    GIRODON, E
    GHANEM, N
    CHASSIGNOL, M
    THUONG, NT
    DUPRET, D
    GOOSSENS, M
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (04) : 393 - 397
  • [15] CDP571, A HUMANIZED ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA - SAFETY, PHARMACOKINETICS, IMMUNE-RESPONSE, AND INFLUENCE OF THE ANTIBODY ON CYTOKINE CONCENTRATIONS IN PATIENTS WITH SEPTIC SHOCK
    DHAINAUT, JFA
    VINCENT, JL
    RICHARD, C
    LEJEUNE, P
    MARTIN, C
    FIEROBE, L
    STEPHENS, S
    NEY, UM
    SOPWITH, M
    MERCAT, A
    EDOUARD, A
    FRIEDMAN, G
    MARIN, N
    SCHLEMMER, B
    LEPAPE, A
    NOVAK, C
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (09) : 1461 - 1469
  • [16] Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock
    Dinarello, CA
    [J]. CHEST, 1997, 112 (06) : 321S - 329S
  • [17] TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 IN THE SERUM OF CHILDREN WITH SEVERE INFECTIOUS PURPURA
    GIRARDIN, E
    GRAU, GE
    DAYER, JM
    ROUXLOMBARD, P
    LAMBERT, PH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (07) : 397 - 400
  • [18] Association of an HLA-DQ allele with clinical tuberculosis
    Goldfeld, AE
    Delgado, JC
    Thim, S
    Bozon, MV
    Uglialoro, AM
    Turbay, D
    Cohen, C
    Yunis, EJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (03): : 226 - 228
  • [19] PARAMETERS AFFECTING THE YIELD OF DNA FROM HUMAN-BLOOD
    GUSTAFSON, S
    PROPER, JA
    BOWIE, EJW
    SOMMER, SS
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 165 (02) : 294 - 299
  • [20] GENETIC-VARIABILITY IN THE TNF-ALPHA PROMOTER IS NOT ASSOCIATED WITH TYPE-II DIABETES-MELLITUS (NIDDM)
    HAMANN, A
    MANTZOROS, C
    VIDALPUIG, A
    FLIER, JS
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (03) : 833 - 839